Abstract Despite innovative progress, cellular therapies have not produced durable, population-level survival gains in glioblastoma. Across 3 major modalities, engineered effectors such as chimeric antigen receptor T cell (CAR-T) and natural killer (NK) cells, immune-education platforms such as dendritic and whole-cell...
Rachael Mooney, E. A. Abd El-Fattah, G. Ngai et al.· Stem Cells Translational Med...· 0 citations
This review delineates how obesity-related SASPs create a permissive environment for cancer initiation and progression and targets the SASPs or the metabolic drivers of senescence as a promising therapeutic strategy to mitigate the potential oncogenic consequences of obesity.
E. A. Abd El-Fattah, G. Ngai, Rachael Mooney et al.· Current Obesity Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.